MedFIT is your opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors.

As a leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access.

Key Figures

High-level speakers

Generated meetings

1,100 meetings realised (in 2018) 

Hosted Events

(in 2018)

Impressions on #MedFIT2018

(during MedFIT 2018)

In-depth Interview with Mirren Mandalia, Johnson & Johnson Innovation Mirren Mandalia: At Johnson & Johnson Innovation, we’re passionate about changing the trajectory of human health for the better...
17 Sep
Pre-book now for the third edition of MedFIT! You wish to connect with the key innovators in medical devices, diagnostics and digital sectors? You would like to discover the most promising start-ups in the MedTech sector ?
16 Jul
MedFIT 2019’s taking shape, discover the brochure! It is also the start of a new (school) year for MedFIT!
06 Sep
4 things to remember about #MedFIT2018 (according to your tweets)

1.  Attendees had a lot of connections with other medtech players 2. Many trends were discussed during the conferences 3. The Start-up Slams were the place to be to discover early-stage ...

12 Jul
[Waiting for #MedFIT2019] Be at the forefront of the medtech news thanks to Medical Plastics News! Interested by news about the design, manufacture and supply of medical plastics devices?
20 Jul
Download the Panorama France Health Tech by France Biotech & Euronext! During MedFIT 2018, France Biotech and Euronext presented the 15th edition of its ‘Panorama France HealthTech’
10 Jul

The Lille Region is the 3rd ranked life sciences cluster in France. The main areas of expertise in the Hauts-de-France region are metabolic diseases, ageing diseases, nutrition and blood related products. The pharma-biotech sector in Northern France enjoys the presence of both big companies (AstraZeneca, Bayer, GSK…), a dense network of innovative startups (AlzProtect, ImaBiotech, Innobiochips…) and dynamic mid-size biopharmaceutical companies (Diagast, Genfit, Genoscreen, LFB…).